Liberum Capital Reaffirms “Buy” Rating for Johnson Matthey (LON:JMAT)

Liberum Capital reaffirmed their buy rating on shares of Johnson Matthey (LON:JMAT) in a research note released on Monday morning, ThisIsMoney.Co.Uk reports.

Other research analysts also recently issued research reports about the stock. HSBC upped their price target on shares of Johnson Matthey from GBX 3,650 ($47.69) to GBX 3,750 ($49.00) and gave the stock a buy rating in a research report on Wednesday, June 5th. UBS Group reaffirmed a sell rating on shares of Johnson Matthey in a research note on Thursday, July 18th. Credit Suisse Group assumed coverage on shares of Johnson Matthey in a research note on Monday, September 2nd. They set an outperform rating and a GBX 4,200 ($54.88) price objective for the company. Deutsche Bank reaffirmed a buy rating on shares of Johnson Matthey in a research note on Thursday, July 18th. Finally, Berenberg Bank reaffirmed a buy rating on shares of Johnson Matthey in a research note on Tuesday, August 20th. One equities research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. Johnson Matthey currently has an average rating of Buy and an average target price of GBX 3,804.29 ($49.71).

JMAT opened at GBX 3,160 ($41.29) on Monday. Johnson Matthey has a twelve month low of GBX 2,574 ($33.63) and a twelve month high of GBX 3,692 ($48.24). The company has a quick ratio of 0.95, a current ratio of 1.64 and a debt-to-equity ratio of 50.40. The company has a 50-day moving average price of GBX 2,985.16 and a 200 day moving average price of GBX 3,160.80. The company has a market cap of $6.12 billion and a PE ratio of 14.73.

In other Johnson Matthey news, insider Robert MacLeod acquired 12 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was bought at an average price of GBX 3,225 ($42.14) per share, with a total value of £387 ($505.68). In the last ninety days, insiders have purchased 36 shares of company stock valued at $110,472.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Read More: Capital gains and your 401(k) or IRA

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.